Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis
- PMID: 29178670
- PMCID: PMC5705477
- DOI: 10.4168/aair.2018.10.1.1
Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis
Conflict of interest statement
There are no financial or other issues that might lead to conflict of interest.
References
-
- Solé D, Rosário Filho NA, Sarinho ES, Camelo-Nunes IC, Barreto BA, Medeiros ML, et al. Prevalence of asthma and allergic diseases in adolescents: nine-year follow-up study (2003–2012) J Pediatr (Rio J) 2015;91:30–35. - PubMed
-
- Ozdoganoglu T, Songu M. The burden of allergic rhinitis and asthma. Ther Adv Respir Dis. 2012;6:11–23. - PubMed
-
- Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2017 Forthcoming. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
